In several cancer cell types, HDAC5 has been linked with reduced acetylation of p53 at K120, which inhibits p53 transcriptional activity and the expression of apoptosis genes, which reduces apoptosis sensitivity [27–29]. Here, HDAC5 is linked to cancer.